Aptalis Pharma Inc. Credit Rating

Usuarios Registrados

Registro para acceso total permitido. Su código de acceso es sensible a mayúsculas y minúsculas.

Nombre de Usuario:

Código de Acceso:

Ingresarme automáticamente en mi próxima visita

Entrar

¿Olvidó su Nombre de Usuario o Código de Acceso?

¿No se ha registrado?

Regístrese ahora para tener acceso GRATUITO a:

Calificaciones de Emisor.

Calificaciones de más de 170,000 instrumentos corporativos, gubernamentales y de finanzas estructuradas.

Calendario de Eventos.

Información de cursos, seminarios y teleconferencias.

Listas de Calificaciones en Observación.

Listados de emisores en revisión para posible cambio de calificación.

Metodologías de Calificación.

Marco de Metodología respaldando todas las calificaciones de Moody’s.

Resultados 1 - 24 de 24

Página 1 de 1 Next

Filtrar por:

Fecha	Tipo de Reporte	Título	Fuente
08 Jan 2014	Rating Action	Moody's reviews Aptalis Pharma ratings for upgrade	Moody's Investors Service
25 Sep 2013	Credit Opinion	Aptalis Pharma Inc.	Moody's Investors Service
24 Sep 2013	Rating Action	Moody's rates Aptalis' new bank facilities B2; outlook positive	Moody's Investors Service
25 Apr 2012	Rating Action	Moody's lowers Aptalis's senior secured to B2; affirms B2 CFR	Moody's Investors Service
30 Mar 2012	Announcement	Moody's comments on proposed Aptalis Pharma refinancing	Moody's Investors Service
30 Mar 2012	Issuer Comment	Aptalis refinancing: Moody's would lower senior secured to B2 and affirm CFR at B2	Moody's Investors Service
26 Oct 2011	LGD Assessment	Aptalis Pharma Inc.	Moody's Investors Service
13 Jun 2011	Covenant Quality Assessment	Aptalis Pharma Inc. (f/k/a Axcan Intermediate Holdings Inc.) / Axcan US Partnership 1 LP - Loan Covenant Quality Snapshot - Amendment and Restatement Agreement (2/11/2011)	Moody's Investors Service
25 Feb 2011	LGD Assessment	Axcan Intermediate Holdings Inc.	Moody's Investors Service
22 Feb 2011	Rating Action	Corrections to Text, February 16, 2011 Release: Moody's affirms Axcan Pharma on final financing terms	Moody's Investors Service
16 Feb 2011	Rating Action	Moody's affirms Axcan Pharma on final financing terms	Moody's Investors Service
04 Feb 2011	Issuer Comment	Moody's: No impact on Axcan ratings on revised financing terms	Moody's Investors Service
01 Feb 2011	Covenant Quality Assessment	Axcan Intermediate Holdings, Inc. - Pre- Sale Snapshot - $225m _% Senior Secured Notes due 2018	Moody's Investors Service
26 Jan 2011	Rating Action	Moody's rates Axcan's new sr. secured debt B1; confirms B2 CFR	Moody's Investors Service
01 Dec 2010	Rating Action	Moody's lowers Axcan to B2, ratings remain under review	Moody's Investors Service
16 Jul 2010	LGD Assessment	Axcan Intermediate Holdings, Inc.	Moody's Investors Service
13 Jul 2010	Rating Action	Moody's confirms Axcan Pharma's B1 CFR; outlook negative	Moody's Investors Service
14 Apr 2010	Rating Action	Moody's reviews Axcan Pharma (B1 CFR) for downgrade	Moody's Investors Service
19 Nov 2009	Announcement	Moody's: Outlook Negative for Global Pharmaceutical Industry	Moody's Investors Service
27 Mar 2009	LGD Assessment	Axcan Intermediate Holdings, Inc.	Moody's Investors Service
27 Mar 2009	Rating Action	Moody's upgrades Axcan's liquidity rating; affirms other ratings	Moody's Investors Service
01 Apr 2008	LGD Assessment	Axcan Intermediate Holdings, Inc.	Moody's Investors Service
22 Feb 2008	Rating Action	Moody's affirms Axcan Intermediate ratings (B1 CFR)	Moody's Investors Service
25 Jan 2008	Rating Action	Moody's assigns B1 to Atom Intermediate (Axcan Pharma); ratings outlook stable	Moody's Investors Service

Resultados 1 - 24 de 24

Página 1 de 1 Next

Estudios & Calificaciones

Productos & Soluciones

Noticias & Eventos

Usuarios Registrados

¿No se ha registrado?

Moody's Integrity Hotline

Via the Internet:

By telephone from the United States:

By telephone from outside the United States: